Novacyt Logo

Novacyt

Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.

ALNOV | PA

Overview

Corporate Details

ISIN(s):
FR0010397232 (+1 more)
LEI:
213800BWAC2BF295EG28
Country:
France
Address:
13 AVENUE MORANE SAULNIER, 78129 VELIZY-VILLACOUBLAY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Novacyt is an international molecular diagnostics company specializing in the design, manufacture, and global supply of in vitro and molecular diagnostic tests. The company provides a broad portfolio of integrated technologies, services, assays, and reagents, with a primary focus on genomic medicine. Its products serve a wide range of applications, including infectious diseases and oncology. Through its specialized business units, such as Primerdesign, Novacyt delivers real-time PCR kits and custom development solutions to a global customer base in human health, food safety, and veterinary diagnostics.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-01 17:00
Declaration of Voting Results & Voting Rights Announcements
Liquidity Agreement Monthly Update and TVR
English 24.3 KB
2025-09-18 08:00
Report Publication Announcement
Notice of Results
English 20.7 KB
2025-09-18 07:00
Report Publication Announcement
Information sur les résultats du 1er semestre 2025
French 219.8 KB
2025-09-15 08:00
Board/Management Information
Appointment of Joint Corporate Broker
English 20.9 KB
2025-09-15 07:00
Board/Management Information
Nomination d'un co-courtier pour l’entreprise
French 218.9 KB
2025-09-12 11:00
Legal Proceedings Report
Resolution re. Lab 21 HSE Prosecution
English 22.3 KB
2025-09-12 07:00
Legal Proceedings Report
Décision concernant les poursuites engagées par le HSE contre Lab 21
French 223.3 KB
2025-08-01 17:02
Declaration of Voting Results & Voting Rights Announcements
Liquidity Agreement Monthly Update & TVR
English 23.7 KB
2025-08-01 16:00
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle sur le contrat de liquidité et sur le nombre total de dro…
French 241.0 KB
2025-07-29 08:00
Interim Report
Half-year trading update
English 25.1 KB
2025-07-15 08:00
Regulatory News Service
Launch of LightBench® Discover
English 23.5 KB
2025-07-15 07:00
Regulatory News Service
Lancement de LightBench® Discover
French 247.4 KB
2025-07-01 14:45
Transaction in Own Shares
Liquidity Agreement Monthly Update and TVR
English 23.7 KB
2025-06-20 07:00
Post-Annual General Meeting Information
Résultat de l’Assemblée Générale Annuelle (AGA)
French 244.2 KB
2025-06-16 07:00
Report Publication Announcement
Publication du rapport annuel
French 215.8 KB

Automate Your Workflow. Get a real-time feed of all Novacyt filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Novacyt via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.